Investor Kit

Company Profile

Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.

Acorda has an industry leading pipeline of novel neurological therapies addressing a range of disorders, including Parkinson's disease, migraine and multiple sclerosis. Acorda markets two FDA-approved therapies, including INBRIJA™ (levodopa inhalation powder).

Stock Chart

Financials

Date Filing Description Download
01/18/19 8-K Current report filing
01/17/19 4 Statement of Changes in Beneficial Ownership
01/15/19 4 Statement of Changes in Beneficial Ownership
01/11/19 4 Statement of Changes in Beneficial Ownership

Stock Quote

ACOR (Common Stock) $ 16.26 -0.63 (-3.73%) Volume: 793,053 MORE January 18, 2019

Email Alerts

Un-subscribe from email alerts
Email Address *
Mailing Lists *





 
Enter the code shown above.